Intralytix Inc., established in 1998, is a pioneering biotechnology company based in the United States, specializing in the development and commercialization of bacteriophage-based products. Their mission is to harness the natural antibacterial properties of bacteriophages—viruses that specifically target and eliminate harmful bacteria—to address bacterial pathogens across various sectors, including environmental, food processing, and medical settings.